Gainplan’s NEOS Enhanced Income 1-3 Month T-Bill ETF CSHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.95M Buy
180,071
+5,940
+3% +$295K 3.47% 4
2026
Q2
$8.67M Sell
174,131
-2,375
-1% -$118K 3.42% 5
2026
Q1
$8.79M Sell
176,506
-7,311
-4% -$363K 6.59% 3
2025
Q4
$9.14M Buy
183,817
+3,965
+2% +$197K 3.43% 5
2025
Q3
$8.94M Buy
179,852
+3,030
+2% +$151K 3.79% 4
2025
Q2
$8.79M Buy
176,822
+12,190
+7% +$605K 3.99% 4
2025
Q1
$8.17M Buy
164,632
+43,591
+36% +$2.17M 5.3% 3
2024
Q4
$6.03M Buy
121,041
+53,283
+79% +$2.66M 2.29% 7
2024
Q3
$3.37M Hold
67,758
– – 1.59% 8
2024
Q2
$3.37M Buy
67,758
+13,620
+25% +$679K 1.63% 8
2024
Q1
$2.7M Buy
54,138
+11,644
+27% +$581K 1.3% 11
2023
Q4
$2.12M Buy
42,494
+10,346
+32% +$517K 1.11% 14
2023
Q3
$1.6M Buy
+32,148
New +$1.61M 2.23% 12

Other funds holding CSHI

Gainplan's CSHI Position: Q3 2026 in Review

Gainplan increased its NEOS Enhanced Income 1-3 Month T-Bill ETF (CSHI) stake by 3.4% in Q3 2026, buying an estimated $295K and bringing the position to 180,071 shares worth $8.95M. The position accounts for 3.47% of the portfolio, ranked #4.

Gainplan first reported a position in CSHI in Q3 2023 and has held it in 13 quarters since. The position peaked at $9.14M in Q4 2025. 17 funds tracked by Wall St. Rank hold CSHI as of Q3 2026.

  • Gainplan held 180,071 shares of NEOS Enhanced Income 1-3 Month T-Bill ETF worth $8.95M as of Q3 2026.
  • Gainplan bought 5,940 NEOS Enhanced Income 1-3 Month T-Bill ETF shares in Q3 2026, an estimated $295K.
  • NEOS Enhanced Income 1-3 Month T-Bill ETF made up 3.47% of Gainplan's portfolio in Q3 2026, its #4 holding.
  • Gainplan first reported a position in NEOS Enhanced Income 1-3 Month T-Bill ETF in Q3 2023 and has held it in 13 quarters since.
  • Gainplan's NEOS Enhanced Income 1-3 Month T-Bill ETF position peaked at $9.14M in Q4 2025.
  • 17 funds tracked by Wall St. Rank held NEOS Enhanced Income 1-3 Month T-Bill ETF as of Q3 2026.

Based on Gainplan's 13F filing for Q3 2026, filed 9 Oct 2026.